Difference between revisions of "DSC MRI Biomarker Ctte"
Jump to navigation
Jump to search
| Line 28: | Line 28: | ||
*[[Media:QIBA_DSC-MRI_Stage1_Profile.pdf |DSC Profile Stage 1 Version for Public Comment]] (comments closed on May 15, 2020) | *[[Media:QIBA_DSC-MRI_Stage1_Profile.pdf |DSC Profile Stage 1 Version for Public Comment]] (comments closed on May 15, 2020) | ||
| − | *DSC Profile Stage 2 Consensus Profile - | + | *[[Media:QIBA_DSC-MRI_Stage2-Consensus_Profile.pdf| DSC Profile Stage 2 Consensus Profile (released 2020-10-22)]] |
| − | |||
<br/> | <br/> | ||
Revision as of 23:31, 6 November 2020
- Co-chairs: Bradley Erickson, MD, PhD; Ona Wu, PhD
- RSNA Staff Support: Susan Stanfa
Project Snapshot
Develop a quantitative imaging profile for Dynamic Susceptibility Contrast MRI.
DSC MRI Meetings
Recent Approved call summaries:
Note: The last meeting of this group was held on October 14, 2020; notes are posted after they are approved by the DSC-MRI BC during the following t-con
DSC-MRI Call Summaries Archive
- Earlier materials can be found on the PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee page
Profile Development
- DSC Profile Stage 1 Version for Public Comment (comments closed on May 15, 2020)
- DSC Profile Stage 2 Consensus Profile (released 2020-10-22)
Historical Background - Formation of the Group
Reference Materials
QIBA Funded Projects
Round 5
- Original Proposal to the QIBA Steering Committee